The News
Neuro3d raises M€ 10 from Existing Shareholders
10/09/2003
2003
- 25/02/2003
-
20/03/2003
Sofinnova Partners and Sofinnova Ventures Host Inaugural CEO Day Conference
- 17/04/2003
- 28/04/2003
- 02/05/2003
-
14/05/2003
Novuspharma SpA Announces Financial Results for the Three Months Ended 31 March 2003
-
05/06/2003
Jean-Bernard Schmidt elected as Association Chairman in 20th year of EVCA
- 05/06/2003
- 05/06/2003
- 17/06/2003
-
07/07/2003
NovusPharma’s Pixantrone Regimen produces high response rates in relapsed aggressive lymphoma
-
28/07/2003
Servista enables Lloyds TSB to launch home energy and telephone services
-
07/08/2003
Novuspharma SpA Announces Financial Results for the Six Months Ended 30 June 2003
- 30/06/2003
-
02/09/2003
Ingenium Appoints Dr. Klaus Dembowsky to Vice President Drug Discovery
-
10/09/2003
Neuro3d raises M€ 10 from Existing Shareholders
-
30/09/2003
Novuspharma Press Release: Financial Results for the nine months ended 30 September 2003
-
23/10/2003
Cell Therapeutics, Inc. and Novuspharma S.p.A Announce Shareholder Approval of Merger
-
28/10/2003
Cellzome Announces Research Collaboration with Johnson & Johnson R&D
- 13/11/2003
- 25/11/2003
-
14/11/2003
Innate Pharma and Novo Nordisk A/S sign licensing deal which opensnew avenue in cancer immunotherapy
- 19/11/2003
-
19/11/2003
Allergan and Exonhit designate target for high throughput screening
-
02/12/2003
The pharmaceutical company Biolipox strengthens Board of Directors with a well known industrialist
-
10/12/2003
Addex Pharmaceuticals SA Signs Three year Clinical Development Partnership with Fulcrum Pharma
- 12/12/2003
- 29/12/2003
- 19/12/2003
- 19/12/2003
